The latest fight over the Democratic Party's direction is playing out in a competitive California House primary, as ...
Secondary analysis from the Phase 3 MAESTRO-NASH and MAESTRO-NAFLD-1 trials examines improvements in lipid profiles for Lp(a), LDL-C and ApoB ...
Not intended for UK and US audiences JASCAYD® (nerandomilast) now approved by Japan’s MHLW for the treatment of adults with idiopathic pulmonary ...
Primary care is essential to advancing population health, yet it has faced underinvestment and workforce shortages in the US. Private equity (PE) investments could expand access by facilitating ...
EMERALD-3: Phase III trial of IMFINZI ® (durvalumab) in combination with IMJUDO ® (tremelimumab-actl), with or without lenvatinib, and transarterial chemoembolization (TACE) in patients with ...
Researchers at the University of Stuttgart's Institute of Information Security have developed a new security standard to ...
This practice had to change when the European Union introduced Right to be Forgotten (RTBF)—first in 2014, as a standalone ...
Thousands of people were already on the Chicago Housing Authority's waitlists when Congress failed to extend funding for an emergency voucher program. Families will now have to wait even longer for ...
A legislative analysis found the tax breaks returned just 1.4 cents per dollar spent, with some showing a negative return on ...
Innovative equipment and digital solutions are evolving rapidly in the present, but future-proofing the critical food space takes research.